|
Sign In to gain access to subscriptions and/or personal tools.
|
Interface Between Pathology and Epidemiology in Carcinogenesis
James S. Campbell
Health Protection Branch, Health and Welfare Canada, Sir Frederick G. Banting Research Centre, Tunney's Pasture, Ottawa, Ontario K1A 0L2, Canada
Leander Tryphonas
Health Protection Branch, Health and Welfare Canada, Sir Frederick G. Banting Research Centre, Tunney's Pasture, Ottawa, Ontario K1A 0L2, Canada
The bottom line here is how or whether our toxicological studies relate to ourselves, to human neoplasia—but the latter is, in important ways, imperfectly defined by the best that can so far be arranged using morphological and epidemiologic methods. There are at least three basic questons: 1) with what precision can the histopathologist define and diagnose cancer in humans—hence emphasis here upon human cancer models, 2) to what extents can difficulties be resolved using animal models, where some similar difficulties are met, and 3) to what extents can epidemiology resolve these difficulties. Not all these problems can be resolved, and the investigator is left with a residue of questions for which no answers are presently available. Some of these are exemplified or precipitated by inconclusive or mistaken diagnoses.
In the future awaits practical help from specific biochemical markers and morphometry, but in the present, vigilance and consultation should limit error to a small fraction of observations. In the meantime, existing methods and data are perfectly adequate for study and action in various clinical problems, eg. transmission of familial polyposis of colon, definition and control of various adverse drug reactions.
- 1. Beer, Stafford: In Designing Freedom, Chapter IV, Science in the Service of Man, p. 58-59. The Massey Lectures, 1973. The Canadian Broadcasting Corporation (CBC Enterprises), Box 500, Station A, Toronto, M5W 1EG.
- 2. Campbell JS, Harrison JR: Current Status of Urea-Formaldehyde Foam Insulation. (Editorial) Canad. Med. Assoc. J., 125:329–330, 1981.
- 3. Campbell JS: Carcinogenesis Workshop. The Sir Frederick G. Banting Research Centre, Health and Welfare Canada. 28 September 1982.
- 4. Final Report of the Department of National Health and Welfare Expert Advisory Committee on Ureaformaldehyde Foam Insulation. Ottawa, April 1981.
- 5. Grice HC: personal communication, 1983. In comment upon Hill AB: The environment and disease: association or causation. Proc. Roy. Soc. Med., 58:295-300, 1965. See also preceding discussion Ibid p. 289-294.
- 6. Harrison JR, Campbell JS: Urea Formaldehyde Foam Insulation. (Review Article) Modern Medicine of Canada, accepted for publication 27 April 1983.
- 7. Irey NS: Tissue Reactions to Drugs. Am. J. Path., 82:617–648, 1976.
- 8. Kreiger N: Formaldehyde and nasal cancer mortality. (letter) Canad. Med. Assoc. J., 128:240, 1983.[Medline]
[Order article via Infotrieve]
- 9. Legg MA: What role for the Diagnostic Pathologist? (Editorial) N. Eng. J. Med., 305(16):950–951, 1981.[Web of Science][Medline]
[Order article via Infotrieve]
- 10. McCaughey WTE: personal communication, 1983.
- 11. Mikhael NZ, Boggs M, Kacew S, Potvin DL: Data abstracted and adapted from The Use of Morphologic Tissue Examination as a Novel Technique for Estimation of Drug Adverse Reactions in Hospitalized Patients. In press: J. Environ. Pathol. Toxicol. Oncol.
- 12. Panel Discussion. The 2nd International Symposium of the Society of Toxicological Pathologists, Arlington, VA, 11 May 1983.
- 13. Proceedings from panel discussion on methylxanthine consumption and fibrocystic breast disease. Cosponsors: National Coffee Association of U.S.A., Inc. Scientific Advisory Group and International Life Sciences Institute, Tarrytown Hilton Conference Center, 17-19 February 1982.
- 14. Report on Urea Formaldehyde Foam Insulation U.F.F.I. Standing Committee on Health, Welfare and Social Affairs. Marcel Roy, MP, Chairman. Peter Lang, MP, MD, Vice-chairman. Ottawa, December 1982.
- 15. Schwartz WB, Wolfe HJ, Pauker SG: Pathology and Probabilities. (Special Article) N. Eng. J. Med., 305(16):917–923, 1981.[Abstract]
- 16. Tryphonas L, Buttar HS: Genital Tract Toxicity of Nonoxynol-9 in Female Rats. Fundamental and Applied Toxicology, 2:211–219, 1982.[CrossRef][Medline]
[Order article via Infotrieve]
- 17. Tryphonas L, Campbell JS, Munro IC: The need to "read" 40 or more Tissues. 1983 Winter Toxicology Forum, Arlington, VA. 22 February 1983.
- 18. Tryphonas L, Buttar HS: Nonoxynol-9 Vaginal Toxicity in Cynomolgus Monkeys. Internal Report, Toxicology Research Division, The Sir Frederick G. Banting Research Centre, Health and Welfare Canada, 1983, to be published.
- 19. Tryphonas L, Buttar HS: Nonoxynol-9 Effects on the Uterus and the Conceptus in the rat. Presented at the Reproductive Biology Workshop of the Department of Obstetrics and Gynecology, University of Ottawa, at the Ottawa Civic Hospital, 11 May 1983.
Toxicologic Pathology, Vol. 11, No. 2,
167-171 (1983)
DOI: 10.1177/019262338301100208
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
